Meso Emerging Active

ABBV vs LLY: Dividend Stocks in Healthcare

New narrative with limited coverage — still forming.

Score 0.2

Velocity ▲ 0.0

Articles 4

Sources 2

Top Movers

Ticker	Sector	Change
ABBV ⚡	Healthcare	+3.1%
JNJ	Healthcare	+2.0%

Active Signals ABBV

Sentiment Timeline

Sector Performance

Stock Performance

Event Timeline

Aug 14, 2026 How ABBV Stock Moved Away From Its Peer Group Neutral

Jul 26, 2026 Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson? Neutral

Jul 10, 2026 2 Recession-Resistant Dividend Stocks to Buy and Hold Bullish

Jul 09, 2026 AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to … Neutral

Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson? Nasdaq · Jul 26, 2026 Mixed

Top Movers

Ticker	Sector	Change
ABBV ⚡	Healthcare	+3.1%
JNJ	Healthcare	+2.0%

Active Signals ABBV

🤖 AI Overview

What happened: Pharmaceutical giants AbbVie (ABBV) and Eli Lilly (LLY) have been compared in recent articles for their dividend growth potential. Both are Dividend Kings, having increased dividends for over 50 years, but they're currently somewhat overvalued. Despite this, their long-term prospects are positive, driven by steady demand for their life-saving drugs. Over the past decade, both have increased their payouts significantly.

Market impact: This narrative affects investors seeking defensive, dividend-paying stocks, particularly in the healthcare sector. It highlights the resilience of these companies during economic downturns, making them attractive for income-oriented investors and those looking to preserve capital during market volatility. The comparison between ABBV and LLY influences investors' decisions on which pharmaceutical stock to add to their portfolios.

What to watch next: AbbVie's earnings report on July 29 will provide insights into its Humira biosimilar competition and potential growth drivers. Eli Lilly's earnings on August 1 will offer updates on its diabetes and cancer treatments. Additionally, investors should monitor any regulatory developments around these companies' drug pipelines, as approvals or setbacks could significantly impact their stock prices and dividend growth prospects.

AI Overview as of Jul 26, 2026

Timeline

First SeenAug 14, 2026

Last UpdatedSep 13, 2026

ABBV vs LLY: Dividend Stocks in Healthcare

Top Movers

Sentiment Timeline

Sector Performance

Stock Performance

Event Timeline

Related Articles